华森制药：接受中信证券调研

Group 1 - Huason Pharmaceutical announced that on October 31, 2025, it will accept research from CITIC Securities, with company representative Zhou Zhiru participating in the reception and answering investor questions [1] Group 2 - Multiple regions are experiencing "negative electricity prices," raising questions about why power plants are reluctant to shut down despite not making profits from selling electricity [1]